Table 8.

Treatment effect of dialysate to serum sodium alignment on volume-related and hemodynamic parameters in those patients part to this quality initiative (as-treated cohort; N = 137) and the propensity score matched control cohort (N = 137)

Parameter	Study Regimen	Baseline	Follow-up	Difference (95% CI)	Treatment effect (95% CI)
Pre HD SBP [mmHg]	aligned	143.42+/−21.27	143.06+/−21.2	−0.36 (−5.41 to 4.69)	1.68 (−0.87 to 4.23)
	unaligned	146.94+/−20.88	144.9+/−22	−2.04 (−7.15 to 3.07)
Post HD SBP [mmHg]	aligned	132.8+/−16.83	133.36+/−17.68	0.56 (−3.55 to 4.67)	1.43 (−0.86 to 3.72)
	unaligned	137.57+/−19.27	136.7+/−19.7	−0.87 (−5.5 to 3.76)
Pre HD DBP [mmHg]	aligned	73.23+/−13.03	72.99+/−12.65	−0.24 (−3.3 to 2.81)	0.43 (−0.94 to 1.8)
	unaligned	75.9+/−12.16	75.2+/−12.1	−0.67 (−3.56 to 2.21)
Post HD DBP [mmHg]	aligned	68.14+/−9.59	68.23+/−10.13	0.09 (−2.26 to 2.44)	0.34 (−0.91 to 1.58)
	unaligned	70.97+/−10.62	70.7+/−10.3	−0.25 (−2.74 to 2.24)
Pre HD PP [mmHg]	aligned	70.19+/−15.3	70.07+/−15.6	−0.12 (−3.79 to 3.56)	1.25 (−0.4 to 2.9)
	unaligned	71.05+/−15.24	69.7+/−15.9	−1.37 (−5.07 to 2.34)
Post HD PP [mmHg]	aligned	64.66+/−13.4	65.13+/−13.7	0.47 (−2.75 to 3.69)	1.09 (−0.38 to 2.57)
	unaligned	66.59+/−13.91	66+/−14.4	−0.62 (−4 to 2.75)
Pre HD MAP [mmHg]	aligned	96.63+/−14.56	96.35+/−14.23	−0.28 (−3.71 to 3.14)	0.85 (−0.83 to 2.52)
	unaligned	99.58+/−13.86	98.5+/−14.3	−1.13 (−4.47 to 2.22)
Post HD MAP [mmHg]	aligned	89.7+/−10.76	89.94+/−11.44	0.25 (−2.4 to 2.89)	0.7 (−0.82 to 2.22)
	unaligned	93.17+/−12.49	92.7+/−12.4	−0.45 (−3.41 to 2.51)
Intra HD SBP change [mmHg]	aligned	−10.61+/−13.72	−9.7+/−14.67	0.92 (−2.46 to 4.3)	−0.25 (−2.65 to 2.14)
	unaligned	−9.38+/−14.23	−8.2+/−14.7	1.17 (−2.27 to 4.61)
Intra HD DBP change [mmHg]	aligned	−5.09+/−6.8	−4.76+/−7.3	0.33 (−1.34 to 2.01)	−0.09 (−1.24 to 1.05)
	unaligned	−4.92+/−6.98	−4.5+/−7	0.43 (−1.23 to 2.09)